# IGF::OT::IGF PHASE I CLINICAL TRIALS FOR DEVELOPMENT OF NEUROTHERAPEUTICS TASK ORDER #001 - PERFORMANCE AREA A - ADMINISTRATIVE AND OVERALL CLINICAL OPERATIONS SUPPORT

> **NIH NIH N01** · PPD DEVELOPMENT, LP · 2020 · $51,605

## Abstract

PHASE I CLINICAL TRIALS FOR DEVELOPMENT OF NEUROTHERAPEUTICS

## Key facts

- **NIH application ID:** 10162362
- **Project number:** 271201600005I-P00005-27100001-1
- **Recipient organization:** PPD DEVELOPMENT, LP
- **Principal Investigator:** MICHAEL GOLD
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $51,605
- **Award type:** —
- **Project period:** 2016-07-08 → 2021-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10162362

## Citation

> US National Institutes of Health, RePORTER application 10162362, IGF::OT::IGF PHASE I CLINICAL TRIALS FOR DEVELOPMENT OF NEUROTHERAPEUTICS TASK ORDER #001 - PERFORMANCE AREA A - ADMINISTRATIVE AND OVERALL CLINICAL OPERATIONS SUPPORT (271201600005I-P00005-27100001-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10162362. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*